|
Meningococcal group a, c, w135, y conjugate vaccines (conjugated to tetanus toxoid carrier protein)
|
Menhibrix
|
GLAXOSMITHKLINE (GSK)
|
|
|
annual
|
|
|
|
TELMISARTAN, HYDROCHLOROTHIAZIDE
|
MICARDIS PLUS
|
BOEHRINGER INGELHEIM
|
|
|
annual
|
|
|
|
TELMISARTAN
|
MICARDIS
|
BOEHRINGER INGELHEIM
|
|
|
annual
|
|
|
|
Meningococcal group a, c, w135, y conjugate vaccines (conjugated to corynebacterium diphtheriae crm197 protein)
|
meningococcal group a, c, w135, y conjugate vaccines (conjugated to Corynebacterium diphtheriae CRM197 protein)
|
GLAXOSMITHKLINE (GSK)
|
|
|
3 years
|
|
|
|
Tenofovir
|
VIREAD
|
GLAXOSMITHKLINE (GSK)
|
|
|
annual
|
|
|
|
Tacrolimus (topical formulations)
|
VIOTOPIC
|
Jazeera Pharmaceutical Industries (JPI)
|
|
|
annual
|
|
|
|
EXENATIDE
|
EXENATIDE
|
AstraZeneca
|
|
|
annual
|
|
|
|
Amoxicillin
|
ULTRAMOX
|
APM
|
|
|
5 years
|
|
|
|
Dimethyl fumarate
|
Tecfidera
|
Algorithm
|
|
|
annual
|
|
|
|
Mepolizumab
|
NUCALA
|
GLAXOSMITHKLINE (GSK)
|
|
|
6 months
|
|
|
